Clinical Trial Update: Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients

View source ↗

Summary

This clinical trial update describes switching patients who are intolerant to bortezomib and newly diagnosed with multiple myeloma to carfilzomib therapy. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Newly Diagnosed Multiple Myeloma | Status: RECRUITING